Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 145-153

  Paris, Daniel ^a   Beaulieu Abdelahad, David ^a   Abdullah, Laila ^a   Bachmeier, Corbin ^a   Ait Ghezala, Ghania ^a   Reed, Jon ^a   Verma, Megha ^a   Crawford, Fiona ^a   Mullan, Michael ^a  

^a ROSKAMP INSTITUTE   (United States)

Author keywords

Alzheimer; Anatabine; Cytokine; Inflammation; LPS; Microglia; NF B; STAT3

Indexed keywords

ANATABINE; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WILD TYPE;

ALKALOIDS; ALZHEIMER DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; CYTOKINES; HEK293 CELLS; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PYRIDINES; STAT3 TRANSCRIPTION FACTOR;

EID: 84871922367     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.017     Document Type: Article

References (41)

1. Y. An, X.L. Qi, J.J. Pei, Z. Tang, Y. Xiao, and Z.Z. Guan Amyloid precursor protein gene mutated at Swedish 670/671 sites in vitro induces changed expression of nicotinic acetylcholine receptors and neurotoxicity Neurochem. Int. 57 2010 647 654
2. B. Brooks-Worrell, and J.P. Palmer Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation Clin. Exp. Immunol. 167 2012 40 46
3. P. Caturegli, A. De Remigis, M. Ferlito, M.A. Landek-Salgado, S. Iwama, S.C. Tzou, and P.W. Ladenson Anatabine ameliorates experimental autoimmune thyroiditis Endocrinology 2012 (Epub ahead of print)
4. P.K. Chatterjee, Y. Al-Abed, B. Sherry, and C.N. Metz Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation Am. J. Physiol. Cell Physiol. 297 2009 C1294 C1306
5. L.E. Chavez-Noriega, A. Gillespie, K.A. Stauderman, J.H. Crona, B.O. Claeps, K.J. Elliott, R.T. Reid, T.S. Rao, G. Velicelebi, M.M. Harpold, E.C. Johnson, and J. Corey-Naeve Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells Neuropharmacology 39 2000 2543 2560
6. G.Y. Chen, and G. Nunez Inflammasomes in intestinal inflammation and cancer Gastroenterology 141 2011 1986 1999
7. W.J. de Jonge, E.P. van der Zanden, F.O. Bijlsma, M.F. van Westerloo, D.J. Bennink, R.J. Berthoud, H.R. Uematsu, S. Akira, S. van den Wijngaard, and R.M. Boeckxstaens, G.E. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway Nat. Immunol. 6 2005 844 851 (Pubitemid 43090471)
8. J.H. Dunn, L.Z. Ellis, and M. Fujita Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma Cancer Lett. 314 2012 24 33
9. S.I. Grivennikov, and M. Karin Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer Cytokine Growth Factor Rev. 21 2010 11 19
10. J. Hao, A.R. Simard, G.H. Turner, J. Wu, P. Whiteaker, R.J. Lukas, and F.D. Shi Attenuation of CNS inflammatory responses by nicotine involves alpha7 and non-alpha7 nicotinic receptors Exp. Neurol. 227 2011 110 119
11. V. Hosur, and R.H. Loring alpha4beta2 nicotinic receptors partially mediate anti-inflammatory effects through Janus kinase 2-signal transducer and activator of transcription 3 but not calcium or cAMP signaling Mol. Pharmacol. 79 2011 167 174
12. Y. Joe, H.J. Kim, S. Kim, J. Chung, M.S. Ko, W.H. Lee, K.C. Chang, J.W. Park, and H.T. Chung Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages J. Biol. Chem. 286 2011 24735 24742
13. G.R. Johnston, and N.R. Webster Cytokines and the immunomodulatory function of the vagus nerve Br. J. Anaesth. 102 2009 453 462
14. P.J. Khandelwal, A.M. Herman, and C.E. Moussa Inflammation in the early stages of neurodegenerative pathology J. Neuroimmunol. 238 2011 1 11
15. M. Kox, J.F. van Velzen, J.C. Pompe, C.W. Hoedemaekers, J.G. van der Hoeven, and P. Pickkers GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation Biochem. Pharmacol. 78 2009 863 872
16. P.E. Leite, J. Lagrota-Candido, L. Moraes, L. D'Elia, D.F. Pinheiro, R.F. da Silva, E.N. Yamasaki, and T. Quirico-Santos Nicotinic acetylcholine receptor activation reduces skeletal muscle inflammation of mdx mice J. Neuroimmunol. 227 2010 44 51
17. T. Li, X. Zuo, Y. Zhou, Y. Wang, H. Zhuang, L. Zhang, H. Zhang, and X. Xiao The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis J. Clin. Immunol. 30 2010 213 220
18. S.F. Liu, and A.B. Malik NF-kappa B activation as a pathological mechanism of septic shock and inflammation Am. J. Physiol. Lung Cell. Mol. Physiol. 290 2006 L622 L645
19. R.J. Lukas, S.A. Norman, and L. Lucero Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y Human neuroblastoma clonal line Mol. Cell. Neurosci. 4 1993 1 12 (Pubitemid 23070130)
20. A. Maciuk, R. Moaddel, J. Haginaka, and I.W. Wainer Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography J. Pharm. Biomed. Anal. 48 2008 238 246
21. E. McGowan, S. Sanders, T. Iwatsubo, A. Takeuchi, T. Saido, C. Zehr, X. Yu, S. Uljon, R. Wang, D. Mann, D. Dickson, and K. Duff Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes Neurobiol. Dis. 6 1999 231 244 (Pubitemid 29470035)
22. M. Mousavi, and E. Hellstrom-Lindahl Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro Neurochem. Int. 54 2009 237 244
23. D. Paris, D. Beaulieu-Abdelahad, C. Bachmeier, J. Reed, G. Ait-Ghezala, A. Bishop, J. Chao, V. Mathura, F. Crawford, and M. Mullan Anatabine lowers Alzheimer's Aβ production in vitro and in vivo Eur. J. Pharmacol. 670 2011 384 391
24. S.Y. Park, Y.H. Baik, J.H. Cho, S. Kim, K.S. Lee, and J.S. Han Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells Cytokine 44 2008 126 134
25. N.S. Patel, D. Paris, V. Mathura, A.N. Quadros, F.C. Crawford, and M.J. Mullan Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease J. Neuroinflammation 2 2005 9
26. V.A. Pavlov, W.R. Parrish, M. Rosas-Ballina, M. Ochani, M. Puerta, K. Ochani, S. Chavan, Y. Al-Abed, and K.J. Tracey Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway Brain Behav. Immun. 23 2009 41 45
27. V.A. Pavlov, and K.J. Tracey The cholinergic anti-inflammatory pathway Brain Behav. Immun. 19 2005 493 499 (Pubitemid 41407697)
28. G. Pena, B. Cai, J. Liu, E.P. van der Zanden, E.A. Deitch, W.J. de Jonge, and L. Ulloa Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis Eur. J. Immunol. 40 2010 2580 2589
29. X. Peng, V. Gerzanich, R. Anand, F. Wang, and J. Lindstrom Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y Mol. Pharmacol. 51 1997 776 784 (Pubitemid 27224682)
30. A. Quadros, N. Patel, R. Crescentini, F. Crawford, D. Paris, and M. Mullan Increased TNFalpha production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice Neurosci. Lett. 353 2003 66 68 (Pubitemid 37464621)
31. G. Schett, L.C. Coates, Z.R. Ash, S. Finzel, and P.G. Conaghan Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future Arthritis Res. Ther. 13 Suppl 1 2011 S4
32. T. Suzuki, I. Hide, A. Matsubara, C. Hama, K. Harada, K. Miyano, M. Andra, H. Matsubayashi, N. Sakai, S. Kohsaka, K. Inoue, and Y. Nakata Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role J. Neurosci. Res. 83 2006 1461 1470 (Pubitemid 43844991)
33. J.F. Thayer Vagal tone and the inflammatory reflex Cleveland Clin. J. Med. 76 Suppl. 2 2009 S23 S26
34. L. Ulloa The vagus nerve and the nicotinic anti-inflammatory pathway Nat. Rev. Drug Discovery 4 2005 673 684 (Pubitemid 41149761)
35. J. Wan, A.K.Y. Fu, F.C.F. Ip, H. Ng, J. Hugon, G. Page, J.H. Wang, K. Lai, Z. Wu, and N.Y. Ip Tyk2/STAT3 signaling mediates β-amyloid-induced neuronal cell death: implication in Alzheimer's disease J. Neurosci. 30 2010 6873 6881
36. H. Wang, H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E.J. Miller, K.J. Tracey, and L. Ulloa Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis Nat. Med. 10 2004 1216 1221 (Pubitemid 39540438)
37. H. Wang, M. Yu, M. Ochani, C.A. Amella, M. Tanovic, S. Susarla, J.H. Li, H. Wang, H. Yang, L. Ulloa, Y. Al-Abed, C.J. Czura, and K.J. Tracey Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Nature 421 2003 384 388 (Pubitemid 36157937)
38. I. Yamamoto, M. Tomizawa, T. Saito, T. Miyamoto, E.C. Walcott, and K. Sumikawa Structural factors contributing to insecticidal and selective actions of neonicotinoids Arch. Insect Biochem. Physiol. 37 1998 24 32 (Pubitemid 128436943)
39. H. Yoshikawa, M. Kurokawa, N. Ozaki, K. Nara, K. Atou, E. Takada, H. Kamochi, and N. Suzuki Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7 Clin. Exp. Immunol. 146 2006 116 123 (Pubitemid 44393846)
40. Y. Zheng, S.E. Gardner, and M.C. Clarke Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease Arteriosclerosis Thromb. Vasc. Biol. 31 2011 2781 2786
41. Y. Zhou, X. Zuo, Y. Li, Y. Wang, H. Zhao, and X. Xiao Nicotine inhibits tumor necrosis factor-alpha induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis Rheumatol. Int. 32 2010 97 104